Christopher Alafi Net Worth & Insider Trades

Christopher Alafi - Director, Intra-Cellular Therapies, Inc

As of May 28, 2021

What is Christopher Alafi's Net Worth?

The current estimated net worth of Intra-Cellular Therapies, Inc's Director, Christopher Alafi, is estimated to be about $29.53M . Christopher Alafi owns about 598,753 units of Intra-Cellular Therapies, Inc common stock. In the last 7 years at Intra-Cellular Therapies, Inc, Christopher Alafi has sold an estimated value of $3.02M worth.

What is Christopher Alafi's Past Insider Trading?

Christopher Alafi's largest purchase order was 625,000 units , worth over $15M on March 12, 2015. Christopher Alafi's largest sale order was 47,325 units , worth over $1.9M on May 28, 2021. In total, Christopher Alafi has made about 53 transactions over 7 years of their time at Intra-Cellular Therapies, Inc. Christopher Alafi usually trades in July, October, June, January and April, with the busiest year in 2019.

Christopher Alafi

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Christopher Alafi's' Mailing Address?

  • Mailing address is P.O. Box 7338 Berkeley CA 94707 CA

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

What are Intra-Cellular Therapies, Inc's Past Insider Trades?

Intra-Cellular Therapies, Inc's most recent insider trade came on December 2, 2022 by Michael Halstead who sold 50,000 units worth $2.69M . In the last 8 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $105.92M and bought an estimated value of $63.6M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director,  Rory Riggs, Director,  and Robert Nostrand Van, Director .

Intra-Cellular Therapies, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1